Aberrant stress and inflammatory responses are key factors in the pathogenesis of obesity and metabolic dysfunction, and the double-stranded RNA-dependent kinase (PKR) has been proposed to play an important role in integrating these pathways. Here, we report the formation of a complex between PKR and TAR RNA-binding protein (TRBP) during metabolic and obesity-induced stress, which is critical for the regulation of eukaryotic translation initiation factor 2 alpha (eIF2a) phosphorylation and c-Jun N-terminal kinase (JNK) activation. We show that TRBP phosphorylation is induced in the setting of metabolic stress, leading to PKR activation. Suppression of hepatic TRBP reduced inflammation, JNK activity, and eIF2a phosphorylation and improved systemic insulin resistance and glucose metabolism, while TRBP overexpression exacerbated the impairment in glucose homeostasis in obese mice. These data indicate that the association between PKR and TRBP integrates metabolism with translational control and inflammatory signaling and plays important roles in metabolic homeostasis and disease.
In Brief
Aberrant stress and inflammatory responses are key factors in the pathogenesis of obesity and metabolic disease. Nakamura et al. show that a critical mechanism driving these responses involves metabolic stressinduced interaction between PKR and RISC-loading complex components, resulting in PKR activation, eIF2a phosphorylation, and JNK activation.
INTRODUCTION
It is established that obesity coexists with a state of metabolic inflammation, also called metaflammation (Hotamisligil, 2006) , in which excess nutrients trigger inflammation and stress responses, including recruitment of immune cells into metabolic tissues, activation of IkB kinase (IKK) and c-Jun N-terminal kinase (JNK) pathways, and elevated production of an array of immune mediators (Donath and Shoelson, 2011; Gregor and Hotamisligil, 2011; Lumeng and Saltiel, 2011; Olefsky and Glass, 2010; Pedersen and Febbraio, 2010; Sabio and Davis, 2010) . Inflammation is a central adaptive and repair mechanism essential for tissue homeostasis and survival (Wernstedt Asterholm et al., 2014) . However, chronic and systemic activation of inflammatory and stress signaling pathways underlies metabolic pathologies such as insulin resistance, type 2 diabetes, and atherosclerosis (Glass and Olefsky, 2012; Jin et al., 2013) . A critical mechanism for metabolic dysfunction in obesity also involves ER stress and dysfunction through direct actions on both insulin signaling and pathways controlling glucose, lipid, and protein metabolism and in crosstalk with inflammatory signaling pathways (Hotamisligil, 2010) . However, it remains unclear how these diverse stress pathways are activated, integrated, and coupled to the regulation of protein translation and metabolic homeostasis under conditions of metabolic challenge.
The unfolded protein response (UPR) is engaged during ER stress as an adaptive response and an attempt to restore homeostasis by suppression of global protein synthesis, stimulation of protein degradation, and synthesis of components of the folding machinery (Hetz, 2012; Malhi and Kaufman, 2011; Ron and Walter, 2007) . However, chronic ER stress and the resulting dysfunctional UPR, in a manner similar to a prolonged inflammatory response, also contribute to pathology, including metabolic deterioration and disease (Fonseca et al., 2011; Malhi and Kaufman, 2011; Hotamisligil, 2010) . One common strategy of cells to control translation during stress is the induction of eIF2a phosphorylation mediated by at least four kinases: double-stranded RNA-dependent kinase (PKR), PKR-like endoplasmic reticulum kinase (PERK), heme-regulated inhibitor kinase (HRI), and general control nonrepressed 2 (GCN2) (Holcik and Sonenberg, 2005) . This pathway is ubiquitously engaged in metabolic tissues such as liver in both obese humans and experimental models, resulting in increased eIF2a phosphorylation and downregulation of global protein synthesis accompanied by reduced polyribosome activity (Fu et al., 2011; Gregor et al., 2009; Karinch et al., 2008; Sharma et al., 2008) . Similarly, JNK activation (Blü her et al., 2009; Ferná ndez-Veledo et al., 2009; Hirosumi et al., 2002; Sourris et al., 2009; Vallerie and Hotamisligil, 2010) and metaflammation (Gregor and Hotamisligil, 2011; Odegaard and Chawla, 2013) are essentially universal to experimental and human obesity and critical for metabolic deterioration. Despite the importance of these signaling events in metabolic homeostasis, the molecular mechanisms by which these stress signaling pathways converge in obesity remain unknown.
We have recently shown that PKR, a pathogen-sensing protein, is activated by excess nutrients and that its aberrant activity plays a key role in metabolic abnormalities under stress (Nakamura et al., 2014; Nakamura et al., 2010) . Similar observations were made in an independently derived strain of PKR-deficient mice (Carvalho-Filho et al., 2012) . Importantly, PKR is involved in eIF2a phosphorylation in mice fed a high-fat diet and is a critical component of inflammasome activation (Lu et al., 2012; Nakamura et al., 2010) , raising the possibility that PKR may function as a common node that responds to both pathogen-and nutrient-induced inflammatory and stress signals in order to suppress insulin action and regulate protein translation under metabolic stress conditions. Exposure of cells and tissues to lipotoxicity also leads to PKR activation and PKR-dependent JNK activation, raising the possibility that PKR serves as a sensor for metabolic stress signals. Indeed, PKR activity and JNK phosphorylation are elevated in multiple tissues in obese humans (Boden et al., 2008; Carvalho et al., 2013; Gregor et al., 2009; Sourris et al., 2009) , strongly suggesting that this role of PKR is conserved and relevant to human disease. However, the mechanism that underlies the assembly of an active PKR complex, and how this complex is coupled to metaflammation, translational suppression, and metabolic dysregulation in obesity, remain unknown. Here, we show that metabolic stress triggers the formation of a PKR complex that features RNA-induced silencing complex (RISC)-loading complex (RLC) proteins and TRBP, resulting in PKR activation and metabolically induced eIF2a phosphorylation, JNK activation, and related inflammatory responses.
RESULTS

Identification of the Components of the PKR Protein Complex in Liver
We and others previously reported that PKR is activated in mouse and human tissues in obesity (Carvalho et al., 2013; Carvalho-Filho et al., 2012; Nakamura et al., 2010) , although the molecular mechanism that underlies this activation remains to be elucidated. We hypothesized that a unique PKR-containing protein complex forms in the obese condition and that the complex component(s) may impact PKR activity, inflammatory responses, and protein translation in obesity. To address this question, we performed biochemical purification and identification of the PKR protein complexes from the liver tissues of lean and obese (ob/ob) mice. We utilized an adenovirus-mediated gene transfer method to deliver hemagglutinin (HA)-tagged PKR into the liver and purified PKR-containing complexes from these compartments using an agarose-conjugated anti-HA monoclonal antibody ( Figure 1A ). Then, we determined the PKR-associated proteins by exhaustive rounds of ''shotgun'' liquid chromatography and tandem mass spectrometry (LC-MS/MS) for protein identification and quantification (Figures 1B and 1C) . These experiments were performed as three independent biological replicates, and statistical analysis of fold-change values (t tests) was used to distinguish PKR-interacting proteins from background signals with high confidence (red and gray dots, respectively, Figures 1B and 1C ; Tables S1 and S2) .
Among the high-confidence PKR interaction molecules, we detected known partners of PKR such as eIF2a (also referred to as eIF2S1), validating our experimental system. PKR has been shown to be a pathogen sensor through its recognition of pathogen-derived double-stranded RNA (dsRNA) (Robertson and Mathews, 1996) . Given that PKR interacts with various proteins involved in RNA processing and biology in the liver, we hypothesized that PKR might be closely integrated with endogenous RNA processing components, particularly under metabolic stress conditions. To test this hypothesis, we analyzed the list of high-confidence PKR interactors in lean and obese liver tissue through enriched Gene Ontology (GO) in biological processes and molecular function categories (Figure 1D ). Enriched GO terms common to lean and obese samples included RNA processing, RNA binding, and protein translation. Interestingly, the functional clades enriched only in the lean samples were found to be associated with metabolism and cellular maintenance, while many of the GO terms enriched only in the obese samples were related to RNA splicing and mRNA processing ( Figure 1D ). These results support the assembly of distinct protein complexes in lean and obese liver tissue and suggest the possibility that PKR complexes detected in liver tissue of obese animals may have specialized metabolic functions.
In an additional analytical approach, we also considered all PKR-exclusive proteins, i.e., proteins categorized with a log 2 (PKR/GFP) ratio over 35, with the postulate that some of the PKR-exclusive proteins may also be of unique functional interest. This analysis yielded additional proteins involved in the regulation of RNA splicing and mRNA metabolism in the samples from obese animals including Dicer, a known component of the RLC (Czech and Hannon, 2011; Kim et al., 2009) , which was observed as a PKR-interacting protein preferentially in obesity (Tables S1 and S2 ). To confirm the interaction, we performed co-immunoprecipitation experiments and found that the PKR-Dicer interaction was enhanced in the liver in the context of obesity ( Figure 1E ). Mammalian Dicer also interacts with two closely related proteins, TAR RNA-binding protein (TRBP) and PACT (Chendrimada et al., 2005; Kim et al., 2009; Lee et al., 2006) , which in turn regulate Dicer stability and contribute to RLC formation (Kok et al., 2007) . In addition, both PACT and TRBP have been shown to interact with PKR, although their significance in inflammatory responses and metabolic regulation is not known and no studies have been conducted to explore their function in obesity (Clerzius et al., 2011) . We found that PKR interacted with TRBP in liver upon exogenous PKR expression and that this interaction was enhanced in obese animals ( Figure 1E ). To evaluate the formation of endogenous complex, we pulled down TRBP from liver lysate and performed western blot analyses with anti-PKR and Dicer antibodies. In this setting, TRBP interaction with PKR was similarly enhanced in the setting of obesity ( Figure S1A ).
PKR Activation Promotes Formation of a Functional Complex
Given that the interactions among PKR, Dicer, and TRBP are enhanced in obesity, a condition in which PKR is also highly activated, we hypothesized that these interactions may be required for or dependent on PKR activity. To investigate these possibilities, we next examined whether treatment with polyinosinic-polycytidylic acid poly(I:C), which mimics virus-derived dsRNA and is one of the strongest known PKR activators (García et al., 2006) , leads to enhanced association between PKR and RLC components. As shown in Figure 2A , poly(I:C) treatment resulted in enhanced interaction among PKR, Dicer, and TRBP in mouse embryonic fibroblasts (MEFs). Similarly, Dicer interaction with PKR was enhanced when PKR was activated by poly(I:C) in hepatocytes ( Figure S1B ).
To further investigate the mechanisms and consequences of the PKR-TRBP and Dicer interactions, we used PKR-deficient MEFs reconstituted with Flag-tagged PKR. The exogenous PKR expression level in Pkr À/À MEFs was comparable to endogenous PKR in Pkr +/+ MEFs and was unaffected by poly(I:C) treatment ( Figure 2B ). Poly(I:C) treatment enhanced the interaction between PKR and endogenous Dicer and TRBP, and formation of this ternary complex was further strengthened in the presence of exogenous TRBP protein ( Figure 2C ). Since PKR's N-terminal region, which contains two dsRNA-binding domains, mediates intermolecular interactions (Cosentino et al., 1995) , we asked whether RNA-binding activity of PKR was critical for the interaction between PKR and RLC. We reconstituted Pkr À/À MEFs with wild-type (WT) and RNA-binding defective PKR (RD), which has point mutations on lysines 64 and 154 in the RNA-binding motifs. A kinase-dead (KD) mutant, which has a point mutation on its lysine 296 residue in the kinase domain, was used as an additional control. The RD mutant lost the ability to interact with TRBP and Dicer, both at baseline and following poly(I:C) stimulation ( Figure 2D ), suggesting that PKR RNA-binding capacity may be required for formation of a ternary complex with Dicer and TRBP. Although the interaction among KD-PKR, Dicer, and TRBP was weaker than that of WT-PKR, this mutant still retained some residual ability to interact with Dicer and TRBP in the presence of poly(I:C) ( Figure 2D ). Importantly, although the RD mutant has an intrinsically intact kinase activity in vitro (data not shown), it did not exhibit poly(I:C)-induced PKR activation ( Figure 2E ), suggesting that formation of a complex with TRBP and Dicer may be important for induction of PKR activity and its downstream functions in this context, including translational and metabolic regulation through eIF2a phosphorylation.
To determine the potential impact of TRBP on eIF2a phosphorylation, we performed immunoprecipitation experiments to pull down TRBP from MEFs expressing HA-tagged TRBP in the presence or absence of PKR. As shown in Figure 2F , TRBP interacted with PKR only when the cells were stimulated by poly(I:C). Importantly, stimulated interaction of TRBP with PKR did not affect the intensity of interaction between TRBP and Dicer. In this setting, as above, poly(I:C) stimulation of complex formation resulted in robust eIF2a phosphorylation ( Figure 2G ). These data implicate the potential involvement of TRBP in translational regulatory pathways through PKR-mediated induction of eIF2a phosphorylation.
TRBP Is Involved in Palmitate-Induced PKR Activation
We previously reported that PKR is activated by palmitate exposure and that the RNA-binding activity of PKR is required for palmitate-induced PKR activation (Nakamura et al., 2010 ).
Thus, we asked whether lipid exposure also triggers the interaction between PKR and the RLC to link this potential mechanism to a metabolic context. As shown in Figure 3A , palmitate treatment resulted in increased interaction between PKR and RLC components, TRBP and Dicer. These interactions also required PKR RNA-binding activity, as they were lost in cells expressing the RD-PKR mutant ( Figure 3B ). Thus the interaction between PKR and RLC may also be responsive to nutrient-induced metabolic stress and PKR activation levels.
We also examined whether other fatty acids could affect PKR activity. To address this question, we treated Pkr À/À MEFs expressing WT-PKR with four different saturated fatty acids (laurate, myristate, palmitate, and stearate) and an unsaturated fatty acid (oleate), followed by PKR kinase assay. As shown in Figure S2A , PKR activity was induced by relatively longer fatty acids palmitate and stearate. Importantly, although the number of carbon atoms is the same between stearate and oleate, oleate was a less effective PKR activator than stearate. As longer saturated fatty acids are intrinsically prone to induce metabolic inflammation compared to unsaturated fatty acids, these data indicate that PKR activity may be a reflection of the level of metabolic stress within cells. Indeed, we observed that eicosapentaenoic acid (EPA) and palmitoleate, unsaturated fatty acids known to lower inflammation and improve metabolic (E) Effects of mutations of PKR on PKR kinase activity. PKR activity was assessed with cell lysates used in Figure 2D using recombinant eIF2a protein.
(F) Interaction of RLC with PKR. Cell lysates were prepared from Pkr À/À MEFs reconstituted with WT PKR and HA-tagged TRBP in the absence or presence of 1 mg/ml poly(I:C) for 1 hr.
(G) Ability of TRBP to induce eIF2a phosphorylation through recruitment of PKR. In vitro kinase assay was performed with cell lysates used in Figure 2F using recombinant eIF2a protein.
homeostasis (Cao et al., 2008; Li et al., 2013; Spann et al., 2012) , did not activate PKR and diminished palmitate-induced PKR activation (Figures S2B and S2C) . Consistent with these observations, palmitate-enhanced interaction between PKR and TRBP was also blocked in the presence of these unsaturated fatty acids ( Figure 3C ). Given that PKR interacts with the RLC in response to metabolic stress, we next examined whether RLC components are critical for palmitate-induced PKR activation. As shown in Figure 3D , palmitate-induced PKR activation was intact in Dicer-deficient MEFs, although the magnitude was moderate. However, palmitate treatment failed to activate PKR in the absence of TRBP ( Figure 3E ). This is an unexpected result, as TRBP can act as an inhibitor of PKR (Clerzius et al., 2011; Park et al., 1994) . Numerous experiments have indicated that PKR is also required for JNK activation in vitro and in vivo (Carvalho-Filho et al., 2012; Goh et al., 2000; Nakamura et al., 2010; Takada et al., 2007) . Consistent with a role for TRBP in PKR activation, palmitate-induced JNK activation, which is also moderate in these cells, as well as eIF2a phosphorylation were diminished in TRBP-deficient fibroblasts ( Figure 3F ). Taken together, these data suggest that although TRBP has been previously considered as an inhibitor of PKR in certain contexts (Clerzius et al., 2011; Park et al., 1994) , its function appears to be more diversified and is regulated by metabolic stress. Furthermore, these observations indicate a requirement for PKR-TRBP complex formation in the activation of PKR in response to nutrient signals and (D and E) Effects of Dicer or TRBP deficiency on palmitate-induced PKR activation. Dicer (D) and TRBP (E) knockout fibroblasts and their control cells were treated with 100 mM palmitate for 2 hr, followed by in vitro PKR kinase assay. Blots shown are representative of three independent experiments; graphs are mean ± SEM (n = 3). *p < 0.05. (F) TRBP deficiency results in reduced palmitate-induced JNK and eIF2a phosphorylation levels. TRBP-knockout fibroblasts and control cells were treated with 100 mM palmitate for 2 hr, followed by western blot analysis. Blots shown are representative of four independent experiments; graphs are mean ± SEM (n = 4). *p < 0.05.
key downstream events such as JNK activation and eIF2a phosphorylation.
TRBP Phosphorylation Links Metabolic Stress to PKR Activation
In the context of interferon-induced PKR activation, it has been proposed that TRBP inhibits PKR function both by dsRNA sequestration and by direct protein-protein interaction (Benkirane et al., 1997; Park et al., 1994) . In contrast, we describe above that metabolic stress induces interaction between TRBP and PKR, leading to PKR activation and suggesting a dual regulatory role for TRBP, as has been reported for some other components of the RLC (Clerzius et al., 2013; Diederichs and Haber, 2007) . In an attempt to gain mechanistic insights into TRBP function, we asked whether a post-translational modification of TRBP might alter its interaction with PKR and differentially regulate its activity. Recently, Paroo et al. reported that four serine residues of TRBP are phosphorylated by the mitogen-activated protein kinase ERK ( Figure 4A ) (Paroo et al., 2009 ). In agreement with this report, we found that expression of constitutively active JNK (MKK7-JNK1) also induced phosphorylation of TRBP, and we determined that this modification occurred predominantly on two of the previously identified residues, S142 and S152 (Figure 4B) . Remarkably, phospho-mimetic (serine-to-aspartate [SD]) variants of TRBP robustly interacted with PKR in the absence of additional stimuli ( Figure 4C ). Conversely, the interaction of the 4SD mutant with the RD-PKR mutant was much weaker than that with WT-PKR ( Figure 4C ), suggesting that PKR RNA-binding activity may be critical for the interaction between PKR and TRBP. Next, we examined the effect of TRBP phosphorylation on PKR kinase activity. In reconstituted Pkr-deficient MEFs, expression of the 4SA TRBP mutant, a non-phospho-mimetic (serine-to-alanine [SA]) variant, moderately suppressed PKR activity, while the 4SD TRBP mutant lacked this activity (Figure 4D ). These data suggest that TRBP phosphorylation in this context may be important not only for interaction with PKR but also for PKR activity. Next, we generated a phospho-specific TRBP antibody that specifically detects TRBP's phospho-serine 152 residue and confirmed specificity by mutational analysis ( Figure S3A ). Using this antibody, we determined TRBP phosphorylation status upon induction of metabolic stress. As shown in Figure 4E , the level of TRBP serine 152 phosphorylation was increased by palmitate exposure, and TRBP phosphorylation was also observed in MEFs treated with poly(I:C) ( Figure S3B ). We then asked whether TRBP phosphorylation was present in the setting of obesity, a context in which PKR is activated (Nakamura et al., 2010) . Indeed, we observed TRBP serine 152 phosphorylation in the liver of obese mice (Figure 4F ). These data suggest that TRBP phosphorylation occurs in response to metabolic stress and is associated with PKR activity.
Metabolic Functions of the PKR-TRBP Axis in Obese Liver
Independent studies previously showed that PKR-deficient mice fed a high-fat diet demonstrate reduced JNK activation and eIF2a phosphorylation and are protected against obesity and insulin resistance (Carvalho-Filho et al., 2012; Nakamura et al., 2010) . Direct regulation of insulin sensitivity and JNK activation by PKR was also shown using a short-term lipid infusion model (Nakamura et al., 2010) . In an attempt to generate a new model to test PKR's effects on JNK activation, eIF2a phosphorylation, and glucose metabolism, we intercrossed PKR-deficient mice with the ob/ob model, which displays severe obesity with insulin resistance and hyperglycemia. Importantly, in the C57BL/6J-ob/ ob genetic background, Pkr À/À and Pkr +/+ mice exhibited similar body weights ( Figure 5A ) with only a minor difference in adiposity (data not shown). However, in glucose tolerance tests (GTTs), Pkr
ob/ob mice showed significantly improved glucose clearance after a glucose challenge compared to controls at 7 weeks of age ( Figure 5B ). Similarly, during insulin tolerance tests (ITTs), 9-week-old Pkr À/À ob/ob mice were more insulin sensitive than Pkr +/+ ob/ob ( Figure 5C ). Consistent with these observations, fasting blood glucose levels of ob/ob mice lacking PKR were significantly lower than those of Pkr +/+ ob/ob controls, while serum insulin levels were comparable between the groups ( Figures 5D and 5E ). In addition, levels of circulating triglyceride, Figures S4A-S4C . (F and G) JNK1 kinase activity (F), which was measured by a kinase assay using immunopurified JNK1, ATP [g-32P] , and recombinant c-Jun protein as substrate, and phosphorylation level of eIF2a on serine 52 (G), which was detected by anti-phospho-eIF2a antibody, in liver of Pkr cholesterol, and very-low-density lipoprotein (VLDL) in Pkr À/À ob/ ob mice were significantly reduced compared to those in Pkr +/+ ob/ob controls ( Figures S4A-S4C ). We next assessed the contribution of PKR to obesity-induced JNK activity and eIF2a phosphorylation in this setting. As shown in Figure 5F , JNK activation was highly induced in liver of Pkr +/+ ob/ob compared to that of lean mice, as expected (Hirosumi et al., 2002; Sreejayan et al., 2008) . In contrast, activation levels of JNK in liver of Pkr À/À ob/ob mice were significantly lower than those detected in Pkr
ob/ob controls. Similarly, the increased eIF2a phosphorylation seen in the liver of ob/ob mice in numerous independent studies (Ozcan et al., 2004; Sreejayan et al., 2008; Tsutsumi et al., 2011; Yang et al., 2010) was significantly reduced to levels close to lean controls upon loss of PKR ( Figure 5G ). Of note, activation of PERK, the ER resident eIF2a kinase, remained elevated in liver of Pkr À/À ob/ob mice ( Figure S4D ). These data indicate that PKR is the dominant mediator of hepatic JNK activation and eIF2a phosphorylation in obesity. In addition, consistent with previous observations (Nakamura et al., 2010 (Nakamura et al., , 2014 , we also confirmed that obesityinduced IRS1 serine phosphorylation levels were decreased in the absence of PKR in this setting ( Figure 5H ). We next utilized the ob/ob model to investigate the role of TRBP in obesity using adenovirus-mediated gene transfer to exogenously express TRBP in liver and examine the effects on glucose metabolism, JNK activation, and eIF2a phosphorylation. The ob/ob mice overexpressing TRBP in liver exhibited similar weight gain and liver weight compared to a control group (Figures 6A and 6B) . However, enhanced expression of TRBP in liver of ob/ob mice resulted in a small but significant increase in fasting glucose levels ( Figure 6C ) and a further deterioration of glucose tolerance as determined by GTTs compared to control mice ( Figure 6D ). Importantly, we observed that TRBP overexpression in liver led to further induction of JNK activation and a further increase in hepatic eIF2a phosphorylation compared to the controls ( Figure 6E ). Next, we asked whether the TRBPinduced JNK activation and eIF2a phosphorylation were dependent on PKR function using adenoviral expression systems. As shown in Figure 6F , PKR-deficient ob/ob mice showed decreased levels of JNK activation and eIF2a phosphorylation compared to a PKR-intact control group virally expressing a control gene (Gus). When TRBP was exogenously expressed in liver of PKR-deficient ob/ob mice, the levels of phosphorylated JNK were partially recovered, but eIF2a phosphorylation levels remained low. These data suggest that TRBP requires PKR for induction of eIF2a phosphorylation but may mediate JNK activation in both PKR-dependent and independent manners.
Physiological Roles of TRBP in Obese Liver
Taken together, our observations demonstrate that the complex formation between TRBP and PKR may promote PKR's adverse metabolic functions. To further explore the physiological relevance of the PKR-TRBP axis in obesity, we designed and established a short hairpin RNA (shRNA)-mediated TRBP knockdown system in which TRBP expression levels in cells were reduced $85% (data not shown). Palmitate-induced PKR activation was diminished by shRNA-mediated suppression of TRBP ( Figure 7A ), consistent with our observations in TRBP-deficient fibroblasts ( Figure 3E ). To investigate the consequence of reduced TRBP in obesity, we used an adenoviral system to express shRNAs against TRBP in the liver of ob/ob mice, which reduced TRBP protein expression up to 90% ( Figure 7B ). In this setting, suppression of hepatic TRBP led to reduced steatosis accompanied by decreased liver weight ( Figure 7C ), although body weight remained similar to that of control mice ( Figure 7D ). Suppression of hepatic TRBP also resulted in a significant reduction in fasting blood glucose levels and improved glucose tolerance indicating improved glucose metabolism (Figures 7E and 7F) . This improvement was observed with two independent shRNA constructs, which achieved similar knockdown efficiency. Consistent with these metabolic outcomes, TRBP suppression resulted in significant downregulation of genes involved in hepatic glucose production (G6Pase and PEPCK) as well as lipogenesis (FAS and SCD1) ( Figure 7G ). Importantly, expression levels of inflammatory cytokines (tumor necrosis factor a and interleukin-1b) and ER stress markers (Grp78 and CHOP) were also significantly reduced following the suppression of hepatic TRBP, while expression levels of b-oxidation-related genes (CPT1 and PGC1a) remained unaffected ( Figure 7G ).
As inflammatory responses, which were assessed by PKR activity and inflammatory cytokine expression, were downregulated upon suppression of hepatic TRBP expression in ob/ob mice, we assessed the effects of hepatic TRBP knockdown on JNK activation. Consistent with results obtained from PKR-deficient ob/ob mice, suppression of hepatic TRBP significantly reduced JNK activity assessed by phosphorylation levels of JNK ( Figure 7H ). In addition, reduced expression of hepatic TRBP resulted in a significant reduction of eIF2a phosphorylation in liver of ob/ob mice ( Figure 7H) , similar to what was observed in the PKR-deficient ob/ob mice ( Figures 5F and 5G ).
We also examined the impact of these alterations on IRS-1 phosphorylation and insulin action in liver. TRBP suppression in obese mice resulted in a significant reduction of IRS1 serine phosphorylation levels ( Figure 7I ) and restoration of insulininduced AKT phosphorylation in liver tissue ( Figure 7J ).
DISCUSSION
Until recently, the main role of PKR has been believed to be the suppression of global protein translation of host cells through induction of eIF2a phosphorylation upon pathogen infection (García et al., 2006) . It is now clear that PKR is also a critical regulator of metabolic homeostasis, placing this enzyme at a critical juncture in immunometabolic pathways (Carvalho-Filho et al., 2012; Nakamura et al., 2010) . Here, we demonstrate that PKR can interact with RLC components to integrate metabolic signals with eIF2a phosphorylation and inflammatory responses. This is not only consistent with the need of host cells to have more efficient and diverse intrinsic strategies to prevent amplification of pathogens but also provides a mechanism by which intrinsic or extrinsic metabolic exposures and stress are linked to immune outputs. As in the case of pathogen exposure, PKR coordinates the eIF2a phosphorylation-mediated suppression of protein translation with the induction of inflammatory responses upon exposure to excess nutrients and energy.
Phosphorylation of eIF2a is considered an important protective event to restore homeostasis upon ER malfunction induced by stresses such as virus infection, accumulation of unfolded or misfolded proteins, lipid overloading, and inflammation (Fu et al., 2011; Holcik and Sonenberg, 2005; Ron and Walter, 2007; Hotamisligil, 2010) . This in turn is believed to lead to a reduction of the ER burden and conservation of cellular energy sources needed to sustain vital processes. If the cellular stress levels are beyond a threshold, cells activate apoptotic or maladaptive pathways such as JNK and p38 signaling (Wagner and Nebreda, 2009; Williams, 2001; Vallerie and Hotamisligil, 2010) . Under obesityinduced chronic metabolic stress, these protective and maladaptive mechanisms co-exist, and thus opposing cellular stress responses compromise the molecular networks that affect regulation of systemic metabolism (Hirosumi et al., 2002; Liu and Cao, 2009; Vallerie and Hotamsilgil, 2010) . Therefore, disordered signaling events may occur and be amplified in obesity, leading to disruption of metabolic homeostasis. It is of critical importance to understand the key regulatory events maintaining chronic stress signaling, and our observations position PKR as a potential regulator of this metastable state.
Signaling through eIF2a is involved in a variety of molecular networks including regulation of development, organelle function, inflammation, and metabolic homeostasis (Holcik and Sonenberg, 2005; Malhi and Kaufman, 2011; Vallerie and Hotamisligil, 2010) . Sustained phosphorylation of eIF2a has been observed as a feature of obesity and insulin resistance in both experimental systems and humans (Gregor et al., 2009; Oyadomari et al., 2008; Ozcan et al., 2004 Ozcan et al., , 2006 Sharma et al., 2008; Sreejayan et al., 2008; Tsutsumi et al., 2011; Wang et al., 2009; Zhou et al., 2009) 
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2009; Gregor et al., 2009; Oyadomari et al., 2008; Ozcan et al., 2004; Sharma et al., 2008; Sreejayan et al., 2008) . However, our findings demonstrate that PKR dominates this regulation in obese liver. Despite the fact that molecular networks of ER stress responses including PERK remain active in Pkr À/À ob/ob mice, eIF2a phosphorylation levels were significantly diminished without a change in body weight. These findings imply that (1) PERK may be engaged in other molecular regulations beyond eIF2a phosphorylation in obese tissues; (2) obesity causes complex cellular stresses, namely metaflammation, and that PKR integrates these inputs into induction of eIF2a phosphorylation and metabolic outcomes; and (3) regulatory factors involved in PKR activation play critical roles as interfaces linking translational deregulation to metabolic dysfunction in obesity. In this regard, identification of Dicer and TRBP as components of the activated PKR complex strongly indicates the possibility of involvement of endogenous double-stranded RNA species, such as snoRNAs (O.A. Youssef, S.A. Safran, T.N., D.A. Nix, G.S.H., B.L. Bass, unpublished data), in addition to potential microbe-derived ligands, in PKR activation in obesity and possibly other metabolic stresses, and identifying these ligands will be an interesting opportunity to pursue in future studies. Integrating the TRBP-RLC and PKR-eIF2a axes could be an efficient strategy that allows cells to respond collectively to environmental and metabolic perturbations. Our data raise the possibility that in certain stress conditions, TRBP and RLC components are involved in the regulation of certain RNA species that induce PKR activation leading to eIF2a phosphorylation. In addition, as protein synthesis is tightly linked to cellular energy consumption, this mechanism may serve to modulate energy utilization in response to metabolic stress in obesity. TRBP is a unique dsRNA-binding protein that has at least two molecular functions: enhancing microRNA (miRNA) maturation processes as a component of the RLC and regulating inflammatory responses by modifying PKR activity. Importantly, these TRBP functions are modulated by phosphorylation induced by mitogen-activated protein kinases (MAPKs) such as ERK and JNK, which are activated in the liver in obesity and involved in pathogenesis of obesity-induced metabolic diseases (Hirosumi et al., 2002; Jiao et al., 2013) . In the setting of metaflammation, TRBP leads to PKR activation as well as enhancement of general miRNA maturation processing (Paroo et al., 2009 ). Co-existence of positive and negative regulatory capacity in RNA binding molecules such as PACT has been reported before and attributed to the stoichiometry of the intermolecular interactions (Clerzius et al., 2013) . Here, we provide evidence that this dual function of TRBP, at least in part, is also regulated by JNK-MAPK-mediated phosphorylation. It is worth noting that obesity constitutes a condition of chronic JNK activation, which through TRBP phosphorylation and other mechanisms contributes to sustained PKR activity and potentially other outcomes such as increased general miRNA expression (Kornfeld et al., 2013) , which are all observed simultaneously. Our finding that TRBP suppression results in alleviation of obesity-induced hepatic steatosis and glucose intolerance suggests a direct role for TRBP in the pathogenesis of obesity and chronic metabolic complications. Recent research suggests that miRNA biogenesis is critical for protecting cells from ER-stress-induced cell death (Cawley et al., 2013) ; therefore, by acting in this pathway as well by mediating JNK activation and eIF2a phosphorylation, TRBP may modulate cellular resistance to metaflammation or its resolution. In chronic metabolic stress conditions, these TRBP-mediated events may contribute to exacerbation of inflammatory responses and deteriorate metabolic homeostasis beyond their adaptive effects.
Notably, PKR activity is highly correlated with JNK activation, and in turn, JNK may phosphorylate TRBP, indicating a regulatory loop between these kinases via TRBP, which may be key to their activation in metabolic context. As the assembly of PKR with RLC is highly associated with PKR and JNK activation, and because PKR can also participate in inflammatory activity (Carvalho-Filho et al., 2012; Lu et al., 2012; Nakamura et al., 2010) , TRBP phosphorylation may be a core component of a signaling node representing the metabolic inflammasome (metaflammasome). Finally, our findings indicate that the inhibition of PKR and TRBP function may result in simultaneous relief from multiple stress responses and may provide new opportunities for clinical applications against chronic stress-related diseases, including obesity-induced metabolic disease and cancer.
EXPERIMENTAL PROCEDURES
Detailed procedures can be found in Supplemental Experimental Procedures.
Mice
Animal care and experimental procedures were performed with approval from the animal care committees of Harvard University. Two different types of targeted mutations of PKR have been established and reported in mice: RNAbinding domain-defective and kinase domain-defective models (Abraham et al., 1999; Baltzis et al., 2002) . In this study, the kinase domain-defective PKR-deficient mice were used, after breeding into the C57Bl/6J genetic background and validation by genome-wide SNP analysis. PKR-deficient mice were then intercrossed with heterozygote animals in the ob (leptin) locus in order to generate PKR-deficient ob/ob mice. GTTs were performed by intraperitoneal glucose injection (0.5 g/kg) following an overnight food withdrawal. ITTs were performed by intraperitoneal insulin injection (3 IU/kg) following a 6 hr daytime food withdrawal. After 10 weeks, these mice were sacrificed and tissues were collected for further analysis. Total body fat mass was assessed by dual energy X-ray absorptiometry (DEXA; PIXImus). Adenovirus carrying HA-tagged PKR, GFP, LacZ-shRNA, or TRBP-shRNA was delivered into the ob/ob or lean mice intravenously at a titer of 3 3 10 11 virus particles/mice. 
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MEF culture
Immortalized Pkr -/-MEFs, which were reconstituted with PKR wild type, RNA-binding inactive, and kinase activity-dead mutants by retrovirus-mediated gene transfer, were used under palmitate or polyinosinic-polycytidylic acid (PolyI:C) stimulation. At 70-80% confluency, cells were placed on DMEM containing 1% cosmic calf serum (CCS) for 14 hours prior to the stimuli.
Sodium palmitate was dissolved in purified water and mixed with DMEM containing 1% CCS.
The palmitate solution and PolyI:C were gently added to the culture dishes in the incubator to prevent any environmental perturbation. For retrovirus production, BOSC23 packaging cells were transfected at 70% confluence with Lipofectamine 2000 (Invitrogen) and a retroviral vector containing Flag-tagged human PKR or HA-tagged human TRBP coding region. After 48 hours, the viral supernatant was harvested and filtered. Cells were incubated overnight with the viral supernatant, supplemented with 8 µg/mL polybrene.
Adenovirus preparation
Expression vectors of adenovirus were constructed by cloning HA-tagged PKR, GFP, LacZshRNA, or TRBP-shRNAs in adenovirus vector pAD/CMV/V5-DEST purchased from Invitrogen (Grand Island, NY). To knockdown TRBP, adenovirus-mediated shRNA expression vectors were constructed by using BLOCK-iT U6 RNAi entry kit (Invitrogen). The sequences for shRNA constructs are listed in Supplementary Table 3 . These viruses were produced as described in Virapower adenovirus system (Invitrogen).
Quantitative real-time PCR analysis
Total RNA was isolated using Trizol reagent (Invitrogen). For reverse transcription, 0.5-1.0 µg of the total RNA was converted to first strand complementary DNA in 20 µl reactions using a high capacity cDNA reverse transcription system (Applied Biosystems, Foster City, CA).
Quantitative real-time PCR analysis was performed using SYBR Green in a real-time PCR machine (7300 Real Time PCR system; Applied Biosystems). The thermal cycling program was 10 min at 95°C for enzyme activation and 45 cycles of denaturation for 15 s at 95°C, 30 s annealing at 58°C and 30 s extension at 72°C. Primers used in the present study are listed in Supplementary Table 4 . To normalize expression data of liver, 36B4 mRNA was used as an internal control gene.
Protein extraction
For protein extraction from MEFs, the cells were washed with cold PBS, followed by lysis in cold lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM NaF, 5% glycerol, 0.5% NP-40, 1% protease inhibitor cocktail]. After homogenization on ice, the cell lysates were centrifuged, and the supernatants were used for western blot analysis. For preparation of liver tissue lysates, the tissues were placed in a cold lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM NaF, 5% glycerol, 1% NP-40, 1% protease inhibitor cocktail]. After homogenization on ice, the tissue lysates were centrifuged, and the supernatants were used for western blot and immunoprecipitation experiments with an agarose-conjugated anti-HA antibody for mass-spec analyses of PKR complexes.
PKR and JNK kinase assays
For PKR kinase assays, MEF lysates containing 300 µg of protein were mixed with magnetic bead-conjugated Flag antibody. The mixture was agitated at 4°C for 3 hours, pelleted by centrifugation and washed three times with lysis buffer followed by two additional washes with PKR kinase buffer [15 mM Hepes (pH7.4), 10 mM MgCl 2 , 40 mM KCl, 2 mM DTT] for equilibration. After treatment with kinase buffer, the beads were incubated in 20 µl kinase buffer containing 0.1 µg of recombinant eIF2a protein and 10 µCi 32 P-γATP (PerkinElmer Life Sciences, Waltham, MA) at 30°C for 20 min followed by SDS-PAGE. For JNK kinase assays, tissue lysates containing 500 µg of protein were mixed with 1 µg of JNK1 antibody and protein G sepharose beads. The mixture was agitated at 4°C for 5 hours, pelleted by centrifugation, and washed three times with the lysis buffer followed by two additional washes with JNK kinase buffer [25 mM Hepes (pH 7.4), 20 mM MgCl 2 , 20 mM β-glycerophosphate, 0.5 mM EGTA, 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 1 mM PMSF] for equilibration. After treatment with kinase buffer, protein at 30°C for 20 min followed by SDS-PAGE.
Immunopurified PKR protein complex digestion
The on-bead digestion protocol was reported earlier (Hubner et al., 2010; Hubner and Mann, 2011 ) and was followed with some modifications outlined below. Immunoprecipitated proteins were incubated with elution buffer [50 mM Tris pH 7.5, 1M urea, 10% methanol, 5 ng/uL trypsin, and 1 mM dithiothreitol] for 1 hour at room temperature followed by a centrifugation at 2,000 x g for 1 minute. The supernatant was removed and transferred to a clean Protein LoBind
Eppendorf tube. The beads were then subjected to two consecutive washes with digestion buffer
[50 mM Tris-HCl pH 7.5, 1M urea, 10% methanol, 5 ng/uL trypsin, 5 mM iodoacetamide]. Each digestion wash was followed by centrifugation at 2,000 x g for 1 min. The supernatants were pooled with the supernatant from the elution step and allowed to digest for an additional 6 hours at room temperature. Then, the peptides were dried under vacuum and resuspended in 5% formic acid, desalted using homemade StageTips packed with C 18 resin from an Empore extraction disk (3M) and equilibrated with 1% formic acid (Rappsilber et al., 2007) . The peptides were eluted from the StageTips using four consecutive elution steps: (1) 50% acetonitrile (ACN) + 1% acetic acid (AA), (2) 50% methanol + 1% AA, (3) 80% ACN + 1% AA, and (4) 80% methanol + 1%
AA. The desalted peptides were dried under vacuum followed by resuspension in 20 µL 5% ACN + 5% formic acid.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
LC-MS/MS data were collected on a LTQ Orbitrap XL mass spectrometer (Thermo Fisher) equipped with an Agilent 1100 series binary HPLC pump, and a Famos autosampler.
Approximately 4 µL of resuspended peptide was loaded onto a 125 µm inner diameter fusedsilica microcapillary with a needle tip pulled to an internal diameter of approximately 10 µm.
The column was packed in-house to a length of 18 cm with a C 18 reverse phase resin (200 Å pore size, 5 µm particle size, Magic C 18 AQ beads, Michrom Bioresources Inc.). The peptides were separated using a 90-minute linear gradient from 4% to 40% buffer B [100% ACN + 0.15%
formic acid] equilibrated with buffer A [3% ACN + 0.125% formic acid] at a flow rate of 1.5 µL/min across the column. The LTQ Orbitrap XL mass spectrometer was operated in the datadependent mode using the TOP10 strategy. In brief, one full MS scan per cycle was acquired, followed by up to 10 collision induced dissociation MS/MS scans on the most abundant precursor ions. Essential precursor mass settings were: AGC, 1x10 6 ; resolution, 6x10 4 ; m/z range, 300-1500; maximum ion time, 500 ms. Essential data dependent MS/MS settings were: AGC, 5x10 3 ; maximum ion time, 150 ms; minimum signal threshold, 1000; isolation width, 2
Da; dynamic exclusion time setting, 20 s; 1+ charged ions and precursor ions for which a charge state could not be assigned were excluded from MS/MS analysis.
LC-MS/MS data analysis
A suite of in-house software tools were used for RAW file processing, controlling peptide, and protein level false discovery rates (Huttlin et al., 2010) . MS/MS spectra were searched using the SEQUEST algorithm (Eng et al., 1994) against an IPI mouse v3.60 database both for forward and reverse sequences. Database search criteria were as follows: tryptic with two missed cleavages, a precursor mass tolerance of 50 ppm, fragment ion mass tolerance of 0.5 Da, static alkylation of cysteine (57.02146 Da), and variable oxidation of methionine (15.99491 Da).
Target-decoy strategy was used to distinguish correct and incorrect spectral identifications and to control the peptide-and protein-level false discovery rates (Elias and Gygi, 2007) . The peptidelevel false discovery rate was restricted to <1% by using linear discriminant analysis based on several different SEQUEST parameters including Xcorr >=1.0, delta-Xcorr, charge state, a minimum peptide length of 7 amino acids, and peptide precursor spectral matches to +/-5 ppm.
The protein false discovery was restricted to <1%.
Label-free Quantification of LC-MS/MS data
Label-free quantitation using extracted ion chromatogram (XIC) peak area was performed using in-house software. All experiments were performed as biological triplicates with the appropriate control triplicates. Peptide level total spectral counts and XIC peak areas were condensed into protein total spectral counts and XIC peak area using in-house software. At this point reverse hits and contaminating protein were removed from the datasets. Proteins that did not have at least one spectral count in all three runs for either the control or experimental group were removed.
Missing spectral count and area values were populated with a value of 0.1. Initial p-values were calculated form triplicate experiments and their corresponding control experiments using a twosample equal variance t-test. Due to the large number of proteins involved in these experiments multiple hypothesis testing was used to control the occurrence of false positive interactors. The
Benjamini-Hochberg false discovery rate method was used to correct the initial p-values.
Significant interactors were determined using a combination of corrected p-values and XIC area Pkr/control ratios.
Bioinformatics analysis of PKR-interacting proteins
Gene ontology analysis was done using the DAVID bioinformatics online resource (http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009a, b) . Enriched GO categories were determined based on 77 significant interactors and 63 significant interactors from lean and obese PKR immunoprecipitation experiments, respectively. The background protein dataset used for GO-analysis contained 5872 total proteins from the mouse liver and was obtained from the "phosphomouse" tissue-specific protein expression study (Huttlin et al., 2010) . Specifically we chose to focus on biological and molecular function categories and restricted the GO categories to a p-value <0.05. The final list of ontologies was manually curated to remove redundant entries, i.e., similar GO terms containing identical IPI numbers.
Statistical analysis
Experimental results are shown as the mean ± SEM. The mean values for biochemical data from each group were compared by Student's t-test. Comparisons between multiple time points were analyzed using repeated-measures analysis of variance, ANOVA. In all tests p < 0.05 was considered significant.
